These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 18071662)

  • 1. Vaccination with messenger RNA (mRNA).
    Pascolo S
    Handb Exp Pharmacol; 2008; (183):221-35. PubMed ID: 18071662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination with messenger RNA.
    Pascolo S
    Methods Mol Med; 2006; 127():23-40. PubMed ID: 16988444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of DNA- and mRNA-transfected mouse dendritic cells as potential vaccines against the human papillomavirus type 16 associated oncoprotein E7.
    Dell K; Klein C; Gissmann L
    Antivir Ther; 2008; 13(4):495-509. PubMed ID: 18672528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.
    Jasani B; Navabi H; Adams M
    Vaccine; 2009 May; 27(25-26):3401-4. PubMed ID: 19200817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor vaccination with synthetic mRNA: strategies for in vitro and in vivo preclinical studies.
    Diken M; Kreiter S; Selmi A; Türeci O; Sahin U
    Methods Mol Biol; 2013; 969():235-46. PubMed ID: 23296938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent.
    Probst J; Weide B; Scheel B; Pichler BJ; Hoerr I; Rammensee HG; Pascolo S
    Gene Ther; 2007 Aug; 14(15):1175-80. PubMed ID: 17476302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of the first phase I/II clinical vaccination trial with direct injection of mRNA.
    Weide B; Carralot JP; Reese A; Scheel B; Eigentler TK; Hoerr I; Rammensee HG; Garbe C; Pascolo S
    J Immunother; 2008; 31(2):180-8. PubMed ID: 18481387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mannosylated and histidylated LPR technology for vaccination with tumor antigen mRNA.
    Pichon C; Midoux P
    Methods Mol Biol; 2013; 969():247-74. PubMed ID: 23296939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of tumor-antigen-encoding mRNA into dendritic cells for vaccination.
    Michiels A; Tuyaerts S; Bonehill A; Heirman C; Corthals J; Thielemans K
    Methods Mol Biol; 2008; 423():155-63. PubMed ID: 18370196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programming human dendritic cells with mRNA.
    Lee J; Boczkowski D; Nair S
    Methods Mol Biol; 2013; 969():111-25. PubMed ID: 23296931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mRNA-based gene transfer as a tool for gene and cell therapy.
    Van Tendeloo VF; Ponsaerts P; Berneman ZN
    Curr Opin Mol Ther; 2007 Oct; 9(5):423-31. PubMed ID: 17932806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phagocytosis of synthetic particulate vaccine delivery systems to program dendritic cells.
    Thiele L; Merkle HP; Walter E
    Expert Rev Vaccines; 2002 Aug; 1(2):215-26. PubMed ID: 12901560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and function of Toll-like receptors on dendritic cells and other antigen presenting cells from non-human primates.
    Ketloy C; Engering A; Srichairatanakul U; Limsalakpetch A; Yongvanitchit K; Pichyangkul S; Ruxrungtham K
    Vet Immunol Immunopathol; 2008 Sep; 125(1-2):18-30. PubMed ID: 18571243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor vaccine therapy against recrudescent tumor using dendritic cells simultaneously transfected with tumor RNA and granulocyte macrophage colony-stimulating factor RNA.
    Naka T; Iwahashi M; Nakamura M; Ojima T; Nakamori M; Ueda K; Katsuda M; Miyazawa M; Ishida K; Yamaue H
    Cancer Sci; 2008 Feb; 99(2):407-13. PubMed ID: 18271939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High performance mRNA transfection through carbonate apatite-cationic liposome conjugates.
    Zohra FT; Chowdhury EH; Akaike T
    Biomaterials; 2009 Aug; 30(23-24):4006-13. PubMed ID: 19410288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of expression and secretion of galectin-3 in human monocyte-derived dendritic cells.
    van Stijn CM; van den Broek M; van de Weerd R; Visser M; Taşdelen I; Tefsen B; van Die I
    Mol Immunol; 2009 Oct; 46(16):3292-9. PubMed ID: 19699526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FLT3 Ligand as a Molecular Adjuvant for Naked RNA Vaccines.
    Kreiter S; Diken M; Selmi A; Petschenka J; Türeci Ö; Sahin U
    Methods Mol Biol; 2016; 1428():163-75. PubMed ID: 27236799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the molecular mechanisms of targeted anti-caries DNA plasmid enhancing antibody responses by gene arrays.
    Xu QA; Yu F; Fan M; Xing Q; Liu G; Liu C
    J Gene Med; 2009 Apr; 11(4):354-60. PubMed ID: 19248140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell vaccines in melanoma: from promise to proof?
    Lesterhuis WJ; Aarntzen EH; De Vries IJ; Schuurhuis DH; Figdor CG; Adema GJ; Punt CJ
    Crit Rev Oncol Hematol; 2008 May; 66(2):118-34. PubMed ID: 18262431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mRNA vaccination as a safe approach for specific protection from type I allergy.
    Weiss R; Scheiblhofer S; Roesler E; Weinberger E; Thalhamer J
    Expert Rev Vaccines; 2012 Jan; 11(1):55-67. PubMed ID: 22149709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.